Market Signal Briefing

President Trump's trade deal with four countries in Latin America could lower prices for coffee, bananas and beef, which have been sore spots for a number of American companies.

HOLLYWOOD, Fla.--(BUSINESS WIRE)--TIC Solutions, Inc. (NYSE: TIC) (the “Company” or “TIC Solutions”), a leading provider of critical asset integrity solutions and tech-enabled, mission-critical Testing, Inspection, Certification, and Compliance (TICC) and engineering services, announced today that its senior leadership will be participating in the 2025 Raymond James Napa Valley Small Cap Symposium on Monday, November 17th, 2025 in Napa, CA. About TIC Solutions: TIC Solutions is a leading provid.

, /PRNewswire/ -- The board of directors of Lowe's Companies, Inc. (NYSE: LOW) has declared a quarterly cash dividend of one dollar and 20 cents ($1.20) per share, payable Feb. 4, 2026, to shareholders of record as of Jan. 21, 2026. 

About Lowe's

Lowe's Companies, Inc. (NYSE: LOW) is a FORTUNE® 100 home improvement company serving approximately 16 million customer transactions a week, with total fiscal 2024 sales of more than $83 billion. Lowe's employs approximately 300,000 associates and operates over 1,700 home improvement stores, 530 branches and 130 distribution centers. Based in Mooresville, N.C., Lowe's supports the communities it serves through programs focused on creating safe, affordable housing, improving community spaces, helping to develop the next generation of skilled trade experts and providing disaster relief to communities in need. For more information, visit Lowes.com.

LOW-IR

Contacts:            

Shareholder / Analyst Inquiries:                

Media Inquiries:

Kate Pearlman

Steve Salazar

704-775-3856

[email protected] 

[email protected]

SOURCE Lowe's Companies, Inc.

Also from this source

MINNEAPOLIS, MN, US, Nov. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported results for its second quarter and first half of fiscal year 2026 ended September 30, 2025.

All comparisons are to the same year-ago period unless otherwise noted.

The company will hold a conference call today at 5:00 p.m. Eastern time to discuss the results for the quarter, followed by a question-and-answer session (see dial-in information below).

Fiscal Q2 Financial Highlights

Revenues totaled $303,000, up 51% from the same year-ago quarter, and making it a record for a second fiscal quarter. The increase was primary due to the introduction of a new product line (PrecisePRP™), sales force and distributor expansion, as well the broadening of addressable market from the large equine market into the larger and faster-growing companion animal market.
Despite the second fiscal quarter traditionally being the lowest quarter of the fiscal year, revenues increased from the previous quarter.
National distributor network sales increased 35% to $237,000, representing 75% of total revenues. During and subsequent to the quarter, the company engaged additional distributors to further its domestic and international expansion.
Gross profit increased from the same year ago quarter by 18% to $220,000 with gross margin of 72.6%. Gross margin improved from 63.8% in the previous quarter.Operating loss increased 12% to $2.1 million, due to increased sales and marketing expenses as the company rolled out the new PrecisePRP™ product line.Net loss increased 31% to $3.0 million or $(0.11) per basic and diluted share. Excluding interest expense (debt discount), net loss improved 6% to $2.1 million.Total liabilities decreased 79% to $1.1 million at September 30, 2025, from $5.1 million at March 31, 2025.Cash totaled $768,000 on September 30, 2025, compared to $228,000 on March 31, 2025, with the increase primarily due to financing activities. Fiscal Q2 Operational Highlights

Uplisted public trading of the company’s common stock from the OTCQB® Venture Market to the OTCQX Best Market, the OTC Markets Group’s highest-level tier. To qualify for the OTCQX®, public companies must meet high financial standards, follow corporate governance best practices, and demonstrate compliance with securities regulations.Entered the European marketplace with the engagement of Nupsala Group to inventory, market and promote throughout the United Kingdom PetVivo’s Spryng with OsteoCushion technology, an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles.Nupsala Group is a leading UK-based veterinary group that operates as both a veterinary wholesaler and referral provider, with a specialization in musculoskeletal (MSK) health, orthobiologics, and regenerative medicine for companion animals and horses.

Initial order has shipped, and the official education and training of Nupsala’s sale force is scheduled to begin mid-January. This new international engagement follows PetVivo’s first entrance into the international market with Eq Especialidades, which was engaged in the previous quarter to distribute PetVivo products in Mexico.

Exhibited at the Texas Equine Veterinary Association 2025 Summer CE Symposium in July where the company demonstrated the research-backed benefits of Spryng to leading veterinarian sports medicine and rehabilitation experts. Such events help drive the greater adoption of Spryng by expanding awareness among key decision-makers of its effectiveness in the management of osteoarthritis in animals.Presented at the Life Sciences Virtual Investor Forum, a leading investor conference series hosted by the OTC Markets Group which provides an interactive forum for publicly traded companies to present directly to investors. The company’s presentation is available for viewing here.Launched three new continuing education (CE) courses for veterinary professionals designed to help deepen their expertise in osteoarthritis (OA), joint injection techniques, and regenerative modalities for canine and equine patients.Advanced the company’s transformative strategic alliance with Digital Landia, a pioneer in Agentic artificial intelligence (AI) solutions. The collaboration centers on Digital Landia’s revolutionary AI technology that deciphers, at 97% accuracy, equine and companion animal behavior and communication through real-time analysis of vocalizations, body language, and physiological signals captured via a smartphone camera. This next generation of AI-powered technology has been integrated with PetVivo’s veterinary products as a first-of-kind global pet care ecosystem. Beta testing continues, with official commercial launch planned in the near future. Continued to ramp up the sales and marketing of PrecisePRP™, a proprietary and revolutionary allogeneic platelet rich plasma (PRP) regenerative product for horses and dogs. Sold under a new exclusive licensing and supply agreement with VetStem signed in February 2025, the product has been receiving favorable reports from veterinarians regarding its ease-of-use.Advanced the new strategic collaboration with Commonwealth Markets, the syndicated ownership group behind the 2023 Kentucky Derby winner. Commonwealth has now integrated both Spryng and PrecisePRP™ into the care protocols of its top-tier thoroughbred stable now that PrecisePRP™ has been approved for equine sales. These two products are now being used as a preventative measure and as a management solution to promote joint health, extend performance longevity, and support recovery in high-impact training and racing environments. Subsequent Events

Joined forces with Veterinary Growth Partners (VGP), a management services organization (MSO) that supports veterinary practices by offering practice management and marketing tools, consulting, and vendor relationships that help them improve the efficiency and profitability of their operations. VGP has committed to actively promoting PetVivo’s Spryng with OsteoCushion Technology and PrecisePRP™ to its expansive member network of more than 7,300 veterinary clinic members across the U.S. Signed an exclusive 10-year white-label licensing agreement with Digital Landia Holding Corp for its breakthrough next-generation Agentic Pet AI technology. The underlying technology features five patent-pending innovations with nine specialized diagnostic agents.The Agentic Pet AI technology addresses two critical challenges facing the veterinary industry: skyrocketing client acquisition costs and the difficulties in capturing the exploding Gen Z pet parent demographic. The implementation of the Agentic Pet AI technology has the potential to deliver a 90% - 98% reduction in client acquisition costs, lowering it from $50 - $150+ per client to just $1.50 - $5.00 per targeted outreach, while simultaneously providing veterinary practices with unprecedented access to this fast-growing segment of Gen Z pet parents.

The official launch is planned in the near future, when it will introduce the Digital Landia’s Agentic Pet B2C app fully integrated with PetVivo's new B2B platform.

Digital Landia announced the publication of a comprehensive technical whitepaper documenting the Agentic Pet AI Framework that will power PetVivo's B2B veterinary-practice platform. The whitepaper validates the technical foundation underlying the platform. It provides veterinary professionals, investors, and industry stakeholders with detailed visibility into the multi-agent artificial intelligence architecture which will enable transformative clinical and economic benefits for veterinary practices.Completed Stage A of the company’s strategic partnership with PiezoBioMembrane, a spin-off from the University of Connecticut that is pioneering biodegradable piezoelectric materials for implantable and regenerative applications. The partnership is advancing the research and development of revolutionary functional biomaterials designed to promote regeneration, restoration and/or remodeling of damaged or injured tissue and bone in animals and humans.Stage A of the three-phase joint research and development project successfully determined that materials of the partners’ respective products can be combined into a single offering that demonstrated piezoelectric activity which may provide therapeutic benefits to animals and humans.

Stage B, now underway, will determine if the combined product can be mass produced at scale and demonstrate a preliminary indication of safety for administration in animals. Stage C, which is expected to begin in the second calendar quarter of next year, will determine definitive safety and efficacy.

Appointed Josh Ruben to PetVivo’s board of directors, bringing to PetVivo a wealth of experience in healthcare and life sciences finance, capital markets and corporate strategy, along with a proven track record in the execution of multi-billion-dollar M&A and capital transactions. His deep understanding of the life sciences industry and strategic insights into growth-stage companies, like PetVivo, will be invaluable as the company continues to expand its market presence. Ruben currently serves as the managing director of Life Sciences at Trinity Capital, focused on venture lending to healthcare companies. He previously served in financial director roles with RBC Capital Markets and Wells Fargo Securities.
Management Commentary

“Our strong growth for the quarter demonstrates the success of our overall strategy for driving greater adoption of our flagship animal osteoarthritis veterinary medical device, Spryng with OsteoCushion Technology,” commented PetVivo CEO, John Lai. “This record performance for a second fiscal quarter also reflects the increasing awareness of PrecisePRP™ for the treatment of osteoarthritis in animals that can be administered alongside Spryng.”

“The combination of Spryng with PresisePRP™ has received very favorable reports from veterinarians regarding the ease-of-use of these products and their effectiveness. We expect PrecisePRP™ revenue to increase at an accelerated pace with the recent reintroduction to the equine market of PrecisePRP™ for horses.”

“We also advanced the research, development and use of other technologies which we gained from the new major partnerships formed over the last several months. These innovative technologies, which includes PrecisePRP™, involve diagnostics and medical treatments that will be transformative for our platform and especially for the veterinarians and pet owners we serve.”

“Since the market introduction of Spryng in late 2021, it has now been used by more than 1,200 veterinary clinics across all 50 states. Now with the recent addition of our first distributor in Europe, which soon followed from our first international distributor we signed in Mexico, we can include several additional international clinics who are now using Spryng.”

“The continued growth in distributor sales, combined with the expansion of our in-house sales force and product offerings, has made it one of our best quarters yet. On a first half comparative basis, revenues were up 85% to more than $600,000, marking our best first fiscal half ever.”

“During the quarter we also advanced our new strategic collaboration with Commonwealth Markets, who has integrated Spryng and PrecisePRP™ into the care protocols of a number of their top-tier thoroughbred stables. By combining our clinical expertise and commercial capabilities with Commonwealth’s vast network, we can provide more veterinarians with cutting-edge, effective solutions that enhance recovery and long-term soundness in competitive horses.”

“As we began our third fiscal quarter, we scored a number of major wins. This includes the new engagement of Veterinary Growth Partners, a management services organization that supports veterinary practices. They have committed to actively promoting Spryng and PrecisePRP™ to their expansive member network of more than 7,300 veterinary hospital clinic members across the U.S.”

“Also following the end of the quarter, we signed an exclusive 10-year white-label licensing agreement with Digital Landia for its patented breakthrough next-generation Agentic Pet AI technology. Our efforts with Digital Landia are now focused on integrating this amazing technology into our platform as a first-of-kind global pet care ecosystem. By aligning our clinically proven therapies with such powerful AI technology, we believe PetVivo is uniquely positioned at the intersection of AI innovation and veterinary care.”

“This week, Digital Landia announced the publication of a comprehensive technical whitepaper documenting the Agentic Pet AI Framework that will power our new PetVivo B2B veterinary-practice platform. Given the strength of this report, we expect our PetVivo AI solution to rival mainstream AI applications in terms of adoption rates, and thereby create tremendous visibility for our brands and technologies. We anticipate the official commercial launch to take place during our fiscal fourth quarter, which will introduce both Digital Landia’s Agentic Pet B2C app and our new B2B platform.”

“We were excited to announce the appointment of Josh Ruben to our board of directors. Josh brings to us a tremendous wealth of experience in healthcare and life sciences finance, capital markets and corporate strategy. We expect his deep understanding of the life sciences industry and strategic insights into growth-stage companies will prove invaluable as we continue to grow and expand our market presence in the veterinary markets and begin to explore the introduction of our products to the human markets. Mr. Ruben is a Managing Director for Trinity Capital and formerly of RBC Capital Markets and Wells Fargo Securities.”

“In the first fiscal quarter of the year, we established a strategic partnership with PiezoBioMembrane, a pioneer in biodegradable piezoelectric materials designed for implantable and regenerative applications. The combination of our two technologies, Spryng and PiezobioMembrane’s piezoelectric material, is creating an exciting new future for PetVivo, one that we believe will be transformative for not only our growth outlook but also for veterinarians and their many precious patients.”

“So far, our three-stage joint research and development project has successfully demonstrated that materials from our mutual products can be combined into a single offering which can generate piezoelectric activity that provides therapeutic benefits to animals and humans. The next stage is now underway to determine if our combined products can be mass produced at scale and demonstrate a preliminary indication of safety for administration in animals. The final stage is expected to begin in the second calendar quarter of next year which will determine definitive safety and efficacy.”

“Altogether, our latest new technologies have created an exciting future for PetVivo that is transformative to not only veterinarians and the patients they serve, but potentially for humans as well. Looking ahead, we expect to see continued strong sales momentum and market penetration for the duration of fiscal 2026 and beyond.”

“In fact, we have never been in a better position to accelerate our growth and expand across high growth markets. The U.S. animal health market is expected to double to $11.3 billion by 2030. Such massive growth is rare for such an already large industry, and it provides us amazing tailwinds.”

“For the full fiscal year ending March 31, 2026, we continue to see another year of record growth and improving bottom line as we continue to expand the use of Spryng and PrecisePRP™, as well advance our other new products on our expanding medical therapeutics platform.”

“The third and fourth quarters of the fiscal year have been traditionally the strongest, particularly given the increase in annual industry events during the third fiscal quarter that typically drive greater product awareness and new orders.”

“As we continue to grow and expand over the coming quarters, we will remain committed to advancing the best in pet health solutions and ensuring our products reach more veterinary professionals and pet owners, with our success in these efforts driving greater value for our stakeholders.”

Fiscal Q2 2026 Financial Summary

Revenues for the second quarter of fiscal 2026 ending September 30, 2025, increased 51% to $303,000. The growth was due to primarily to the new product offerings of PrecisePRP™, continued expansion from the large equine market into the larger and faster-growing companion animal market, as well as expansion of the company’s sales force and distributor network.

Distributor sales increased 35% to $237,000, representing 75% of total revenues.

Gross profit totaled $220,000 or 72.6% of revenues, an increase of 23% from $180,000 or 89.5% of revenues in the same year-ago quarter. The decrease in gross margin was due to the addition of the PrecisePRP™ products.

Operating expenses decreased 3% to $2.3 million from $2.4 million in the year-ago quarter. The reduction in operating expenses was primarily due to reduced research and development costs.

Net loss totaled $3.0 million or $(0.11) per basic and diluted share, increasing 36% from a net loss of $2.2 million or $(0.11) per basic and diluted share in the same year-ago quarter. The increase is due to an increase in interest expense from debt discount, due to the conversion of promissory notes on September 30, 2025. Excluding $942,000 of debt discount (recorded as interest expense), net loss improved 5% to $2.1 million.

Net cash used in operating activities increased to $3.8 million from $3.1 million in the same year-ago quarter. The increase was primarily due to an increase in inventory purchases of the company’s new PrecisePRP™ product line to meet growing demand and trade vendors settlement payments, as accounts payables decreased substantially during the second fiscal quarter.

Cash totaled $768,000 at September 30, 2025, compared to $228,000 at March 31, 2025, with the increase primarily due to financing activities.

Total liabilities decreased 79% to $1.1 million at September 30, 2025, from $5.1 million at March 31, 2025, with the decrease primarily due to the extinguishment of derivative liabilities related to convertible notes, reduction in accounts payables due to settlement payments with trade vendors and the conversion of convertible promissory notes to common stock.

For a more detailed overview of the company’s financials, see the consolidated statements of operations and consolidated balance sheet below.

Fiscal 2026 Outlook

For the full fiscal year ending March 31, 2026, management continues to anticipate another year of record growth and improving bottom line as it continues to expand the use of Spryng with OsteoCushion Technology and PrecisePRP™, as well as other new products offered by PetVivo’s medical therapeutics platform.

The third and fourth quarters of our fiscal year have been traditionally the strongest for the company, particularly given the increase in annual industry events during these periods which typically drive greater product awareness, customer interaction and new orders.

Conference Call
PetVivo management will host a conference call later today to discuss these results, followed by a question-and-answer period.

Date: Friday, November 14, 2025
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Toll-free dial-in number: +1 669 444 9171
Conference ID: 87234562707
Passcode: 396948
Webcast (live and replay): Click Here

A replay of the webcast will be available through the same link following the conference call.

The conference call webcast is also available via a link in the Investors section of the company’s website at petvivo.com/investors.

About PetVivo Holdings

PetVivo Holdings Inc. (OTCQX: PETV; OTCID: PETVW), in cooperation with its wholly owned subsidiary PetVivo Animal Health, Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals.

The company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.

PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protect the Company's biomaterials, products, production processes and methods of use. The Company’s lead products Spryng with OsteoCushion technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP®, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale.

PetVivo uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor the company’s Investor Relations website, in addition to following the company’s press releases, SEC filings, public conference calls, presentations and webcasts.

Forward-Looking Commercial Statements

The foregoing information regarding PetVivo Holdings, Inc. (the “Company”) may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025 and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact

John Lai, CEO
PetVivo Holdings, Inc.
Email Contact
Tel (952) 405-6216

PETVIVO HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

  Three Months Ended
September 30,  Six Months Ended
September 30,   2025  2024  2025  2024 Revenues $303,284  $200,720  $600,784  $324,470                  Cost of Sales  83,226   21,162   194,000   34,156 Gross Profit  220,058   179,558   406,784   290,314                  Operating Expenses:                                 Sales and Marketing  787,262   620,307   1,408,974   1,154,720 Research and Development  261,433   465,174   601,946   852,689 General and Administrative  1,236,730   1,267,117   2,305,548   2,500,378                  Total Operating Expenses  2,285,425   2,352,598   4,316,468   4,507,787                  Operating Loss  (2,065,367)  (2,173,040)  (3,909,684)  (4,217,473)                 Other (Expense) Income                Loss on Disposal of Assets  -   -   (149,125)  - Unrealized Loss on Change in Derivative Liabilities  -   -   (320,404)  - Other Income  -   -   111,518   - Interest Income  -   -   13,099   - Interest Expense  (942,442)  (2,453)  (1,064,250)  (5,083)                 Total Other Income (Expense)  (942,442)  (2,453)  (1,409,162)  (5,083)                 Loss before taxes  (3,007,809)  (2,175,493)  (5,318,846)  (4,222,556)                 Income Tax Provision  -   -   -   -                  Net Loss  (3,007,809)  (2,175,493)  (5,318,846)  (4,222,556)Less: Series B Preferred Stock Dividends  (125,000)  -   (153,603)  - Net Loss Available to Common Stockholders $(3,132,809) $(2,175,493) $(5,472,449) $(4,222,556)                 Net Loss Per Share:                Basic and Diluted $(0.11) $(0.11) $(0.21) $(0.22)                 Weighted Average Common Shares Outstanding:                Basic and Diluted  27,579,136   20,099,095   25,949,915   19,395,401 
See accompanying notes to these unaudited condensed consolidated financial statements.

PETVIVO HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)

  September 30, 2025  March 31, 2025        Assets:        Current Assets        Cash $767,914  $227,689 Accounts receivable, net of allowance for credit losses  137,999   60,573 Subscriptions receivable  -   4,400,000 Inventory (Note 2)  578,293   323,504 Investments  150,000   150,000 Prepaid expenses and other assets (Note 3)  475,517   447,801 Total Current Assets  2,109,723   5,609,567          Property and Equipment, net (Note 4)  482,885   766,874          Other Assets:        Operating lease right-of-use  86,318   961,539 Patents and trademarks, net (Note 5)  21,624   23,725 Licensing Agreements, net (Note 6)  2,544,889   1,950,000 Security deposit  12,830   27,490 Total Other Assets  2,665,661   2,962,754 Total Assets $5,258,269  $9,339,195          Liabilities and Stockholders’ Equity:                 Current Liabilities        Accounts payable $370,243  $821,081 Accrued expenses (Note 7)  618,736   948,554 Operating lease liabilities – current portion  63,715   163,834 Notes payable and accrued interest – current portion (Note 8)  -   312,865 Convertible notes payable and accrued interest, net of debt discount of $0 and $149,644 (Note 9)  -   1,622,377          Derivative liabilities  -   448,089 Total Current Liabilities  1,052,694   4,316,800 Other Liabilities        Operating lease liabilities (net of current portion)  22,603   797,705 Notes payable and accrued interest (net of current portion) (Note 9)  -   5,442 Total Other Liabilities  22,603   803,147 Total Liabilities  1,075,297   5,119,947          Commitments and Contingencies (see Note 11)        Stockholders’ Equity: (Note 13)        Preferred Stock, par value $0.001, 20,000,000 shares authorized:        Series A Preferred stock: 0 and 3,045,000 shares issued and outstanding at September 30, 2025 and March 31, 2025  -   3,045 Series B Preferred stock: 5,000,000 shares issued and outstanding at September 30, 2025 and March 31, 2025  5,000   5,000          Common Stock, par value $0.001, 250,000,000 shares authorized, 32,954,679 and 24,181,537 issued and outstanding at September 30, 2025 and March 31, 2025, respectively  32,955   24,182 Additional Paid-In Capital  100,815,956   95,385,511 Accumulated Deficit  (96,670,939)  (91,198,490)Total Stockholders’ Equity  4,182,972   4,219,248 Total Liabilities and Stockholders’ Equity $5,258,269  $9,339,195 
See accompanying notes to these unaudited condensed consolidated financial statements.

Tech stocks have at times appeared unstoppable this year. Now they're in a rut.

SAN DIEGO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), (the “Company”), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation, energy security and smart city infrastructure, today announced its third quarter results for the period ended September 30, 2025.

Recent Operational Highlights

 ●Opened Beam Middle East offices and entered the MEA market through a joint venture with the Platinum Group in Abu Dhabi ●Deployed EV ARC™ and BeamBike™ systems in Abu Dhabi ●Deployed BeamWell™ product in Jordan for Royal Jordanian Armed Forces ●Deployed BeamBike™ product for tribal communities in the United States ●Signed reselling agreements with multiple qualified representatives in U.S. and Europe ●Granted renewal of General Services Administration (GSA) Multiple Award Schedule (MAS) contract through October 31, 2030, enabling federal, state and local governments to purchase the Company’s products through the GSA MAS program ●Awarded purchasing contract by Sourcewell enabling federal, state and local government agencies, and higher education institutions across North America to easily purchase Beam Global products without the requirement for competitive bidding or RFP processes ●Granted several new valuable patents which increase barrier to entry for competition and further reinforce Beam Global’s moat ●Received TUV SUD 1090-2 EXC4 Level certification at Beam Europe ●Shipped Beam Global products to Arizona, California, Colorado, Florida, Michigan, New Jersey, Nevada, Texas, Washington, Quebec, Illinois, Ontario, Alabama and internationally to Serbia, Romania, Greece, North Macedonia, Bosnia, Herzegovina, Croatia and Montenegro
Financial Highlights

 ●67% of Revenues from Non-Government Commercial Entities Q3 YTD '25 ●39% of Revenues from International operations Q3 YTD '25 ●Q3 YTD '25 Gross Margin 10%. Adjusted non-GAAP Gross Margin, net of non-cash costs, 22%, a 4-percentage point increase over non-cash Q3 YTD '24 ●Q3 YTD '25 Operating expenses adjusted for non-GAAP, net of non-cash costs, reduced by $1.9 million, a 14-percentage point improvement over Q3 YTD '24 ●Contracted backlog of $8 million ●Debt free and $100 million line of credit available and unused
“Although we had some unfortunate order timing in the 3rd quarter we simultaneously took some of the most important steps in our history for growth,” said Desmond Wheatley, CEO of Beam Global. “Our expansion into the Middle East, a market, which has announced it will invest $1 trillion in the next decade in sustainable infrastructure, has created new opportunities, not just for global growth, but also for a fantastic evolution of the uses of our products for drones and autonomous vehicles. Beam Global has always been a little ahead of its time, but now we’re finding that our superior battery technology, our ability to rapidly and autonomously deploy sustainable charging infrastructure which can charge autonomous vehicles, wirelessly, without any human intervention, and some of our other products like our BeamFlight™ (formerly UAV ARC) rapidly deployed and autonomous drone recharging product, are coming-of-age, particularly in markets like the Middle East where there is significant investment and a less burdensome regulatory environment. Electric bicycles are the fastest growing segment in mobility today globally and our approach to that market with BeamBike™ is the most rapidly deployed and scalable approach I’m aware of. Our ability to deploy electric bikes and charging infrastructure without construction or electrical work and without a utility bill put us in a position to compete for recurring revenue in a market where others are burdened by the costs, resources and risks associated with those activities. The successful deployment of BeamBike™ both in the United States and Abu Dhabi, is proof that there’s a great market for these products as well. We had some orders move right in the third quarter, but we will execute on them in the near future and in the meantime, we will continue to focus heavily on all the new opportunities that we have as a result of the expansion of our product portfolio and geographic footprint. We did all of this while remaining debt free, reducing our operating costs, maintaining sufficient cash and operating capital, and improving almost every other aspect of our operations.”

Revenues

For the quarter ended September 30, 2025, the Company’s revenues were $5.8 million, a decrease of 50%, driven largely by unfavorable order timing, compared to $11.5 million for the quarter ended September 30, 2024. Revenues derived from non-government, commercial entities represented 82% of total revenues for the three months ended September 30, 2025, compared to 48% for the three months ended September 30, 2024.

For the nine months ended September 30, 2025, the Company’s revenues decreased 53% to $19.2 million compared to $40.9 million for the same period in 2024 driven largely by a reversal of the U.S. federal government’s commitment to electrify its fleets. Revenues to non-government, commercial entities grew to 67% of total revenues for the first nine months ended September 30, 2025, compared to 31% for the same period in 2024. International customers grew to 39% of the revenues for the first nine months of 2025 compared to 20% for the same period in 2024.

Gross Profit

Gross margin for the quarter ended September 30, 2025, was -1% as the Company reported a gross loss of $28 thousand driven by the impacts of fixed overhead allocations on reduced reported sales, compared to a 11% gross margin or gross profit of $1.2 million in 2024. The gross profit for 2025 and 2024 includes a non-cash negative impact of $0.6 million for depreciation and $0.2 million for amortization of intangible assets resulting from the All-Cell acquisition. Without these non-cash expenses, gross profit for 2025 would be $0.7 million with a 13% gross margin and gross profit for 2024 would be $2.0 million with an 18% gross margin.

Gross margin for the nine months ended September 30, 2025, was 10% compared to a gross margin of 12% for the same period ended 2024. The nine months ended September 30, 2025 excluding non-cash items of depreciation and intangible amortization, was 22% compared to 18%, a 4-percentage point increase.

The Company has continued to recognize synergies and report positive gross margins from the Company's acquisitions. We expect the Company’s revenue to grow in the future and the Company’s fixed overhead absorption to improve.

Operating Expenses

Total operating expenses were $4.8 million for the three months ended September 30, 2025, compared to a credit of $50 thousand in 2024. The 2024 operating expenses included a $6.1 million-dollar non-cash change in fair value of contingent consideration for the Amiga acquisition. The third quarter 2025 operating expenses, excluding non-cash items, was $3.6 million compared to $5.1 million for the same period in 2024, an improvement of $1.5 million or 30-percentage points. The decrease in expenses year over year is mostly attributable to efficiencies driving a decrease of $0.6 million for salaries, benefits and related costs, $0.3 million decrease in sales and marketing costs and $0.3 million in other G&A.

Total operating expenses were $26.8 million for the nine months ended September 30, 2025 compared to $11.6 million for the same period in 2024. The 2025 operating expenses include non-cash totaling $15.4 million which is mainly $10.8 million for the impairment of goodwill recorded in Q2 2025. The nine months ending September 2025, excluding non-cash items, is $11.4 million, an improvement of $1.9 million and 14-percentage points, over the same period in 2024.

Net Loss

Net Loss was $4.9 million for the three months ended September 30, 2025, compared to $1.3 million Net Profit for the same period in 2024. The third quarter 2025 net loss excluding non-cash items was $2.8 million compared to $3.0 million for the same period in 2024, an improvement of $0.2 million or 7-percentage points.

Net Loss was $24.7 million for the nine months ended September 30, 2025, compared to $6.7 million for the same period in 2024. The 2025 Net Loss excluding non-cash items was $7.0 million compared to $5.8 million for the same period in 2024.

Cash

On September 30, 2025, the Company had cash of $3.3 million, compared to $4.6 million on December 31, 2024. The Company had working capital of $10.9 million on September 30, 2025.

The Company has historically met cash needs through a combination of debt and equity financing and more recently through increasing gross profit contributions. The Company’s cash requirements are generally for operating activities and acquisitions.

Non-GAAP Financial Measures

To supplement the Company’s condensed consolidated financial statements, which are prepared in accordance with GAAP, the Company presents Non-GAAP financial measures, in this press release. The Company uses Non-GAAP in conjunction with GAAP measures as part of the Company’s overall assessment of the Company’s performance to evaluate the effectiveness of the Company’s business strategies and to communicate with the Company’s board of directors concerning the Company’s financial performance. The Company believes Non-GAAP is also helpful to investors, analysts and other interested parties because it can assist in providing a more consistent and comparable overview of the Company’s operations across the Company’s historical financial periods. Non-GAAP has limitations as an analytical tool. Therefore, you should not consider it in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. Because of these limitations, you should consider Non-GAAP measurements alongside other financial performance measures, including attributable to other GAAP measures. In evaluating Non-GAAP measures you should be aware that in the future, the Company may incur expenses that are the same as, or similar to, some of the adjustments reflected in this press release. The Company’s presentation of Non-GAAP should not be construed to imply that the Company’s future results will be unaffected by the types of items excluded from the calculations of Non-GAAP measures. Non-GAAP is not presented in accordance with GAAP and the use of these terms vary from others in the Company’s industry.

Conference Call November 14, 2025 at 4:30 p.m. ET 

Management will host a conference call on Friday November 14, 2025 at 4:30 p.m. ET to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session.

Participants can register for the conference through the following link: https://dpregister.com/sreg/10204646/10064dbe030

Please note that registered participants will receive their call-in number upon registration.

Those without internet access or unable to pre-register may call in by calling:

PARTICIPANT CALL IN (TOLL FREE): 1-844-739-3880

PARTICIPANT INTERNATIONAL CALL IN: 1-412-317-5716

Please ask to join the Beam Global call.

About Beam Global

Beam Global is a clean technology innovator which develops and manufactures sustainable infrastructure products and technologies. We operate at the nexus of clean energy and transportation with a focus on sustainable energy infrastructure, rapidly deployed and scalable EV charging solutions, safe energy storage, energy security and Smart Cities Infrastructure. With operations in the U.S., Europe and the Middle East, Beam Global develops, patents, designs, engineers and manufactures unique and advanced clean technology solutions that power transportation, provide secure sources of electricity, enable Smart City services, save time and money, and protect the environment. Beam Global is headquartered in San Diego, CA with facilities in Broadview, IL, Belgrade and Kraljevo, Serbia and Abu Dhabi, UAE. Beam Global is listed on Nasdaq under the symbol BEEM. For more information visit, BeamForAll.com, LinkedIn, YouTube, Instagram and X.

Forward-Looking Statements

This Beam Global Press Release may contain forward-looking statements. All statements in this Press Release other than statements of historical facts are forward-looking statements. Forward-looking statements are generally accompanied by terms or phrases such as “estimate,” “project,” “predict,” “believe,” “expect,” “anticipate,” “target,” “plan,” “intend,” “seek,” “goal,” “will,” “should,” “may,” or other words and similar expressions that convey the uncertainty of future events or results. These statements relate to future events or future results of operations. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause Beam Global’s actual results to be materially different from these forward-looking statements. Except to the extent required by law, Beam Global expressly disclaims any obligation to update any forward-looking statements.

Investor Relations
Luke Higgins
+1 858-261-7646
[email protected]

Media Contact
Lisa Potok
+1 858-327-9123
[email protected]

Beam Global
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)  September 30,  December 31,   2025  2024   (Unaudited)     Assets        Current assets        Cash $3,348  $4,572 Accounts receivable, net of allowance for credit losses of $504 and $259  5,891   8,027 Prepaid expenses and other current assets  1,554   2,243 Inventory, net  11,137   12,284 Total current assets  21,930   27,126          Property and equipment, net  13,588   13,704 Operating lease right of use assets  1,612   1,893 Goodwill  –   10,580 Intangible assets, net  7,349   8,037 Deposits  122   119 Total assets $44,601  $61,459          Liabilities and Stockholders' Equity        Current liabilities        Accounts payable $6,316  $8,959 Accrued expenses  1,877   2,462 Sales tax payable  512   195 Deferred revenue, current  1,564   847 Note payable, current  67   63 Contingent consideration, current  166   93 Operating lease liabilities, current  577   696 Total current liabilities  11,079   13,315          Deferred revenue, noncurrent  759   800 Note payable, noncurrent  148   199 Contingent consideration, noncurrent  –   216 Other liabilities, noncurrent  3,403   3,380 Deferred tax liabilities, noncurrent  1,926   1,290 Operating lease liabilities, noncurrent  765   971 Total liabilities  18,080   20,171          Stockholders' equity        Preferred stock, $0.001 par value, 10,000,000 authorized, none outstanding as of September 30, 2025 and December 31, 2024  –   – Common stock, $0.001 par value, 350,000,000 shares authorized, 18,662,502 and 14,835,630 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively  19   15 Additional paid-in-capital  155,987   147,072 Accumulated deficit  (129,314)  (104,643)Accumulated Other Comprehensive Income (AOCI)  (171)  (1,156)         Total stockholders' equity  26,521   41,288          Total liabilities and stockholders' equity $44,601  $61,459  Beam Global
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited, In thousands except per share data)  Three Months Ended  Nine Months Ended   September 30,  September 30,   2025  2024  2025  2024                  Revenues $5,788  $11,482  $19,187  $40,855                  Cost of revenues  5,816   10,251   17,280   35,789                  Gross (loss) income  (28)  1,231   1,907   5,066                                   Operating expenses  4,844   (51)  16,010   11,623                  Impairment of goodwill  –   –   10,780   –                  (Loss) income from operations  (4,872)  1,282   (24,883)  (6,557)                 Other income (expense)                Interest income  14   58   51   167 Other (expense) income  (5)  (33)  181   (238)Interest expense  (7)  (10)  (20)  (28)Other income (expense)  2   15   212   (99)                 Net (Loss) income $(4,870) $1,297  $(24,671) $(6,656)                 Net foreign currency translation (expense) benefit  (109)  673   985   249                  Total Comprehensive (loss) income $(4,979) $1,970   (23,686) $(6,407)                 Net (loss) income per share – basic $(0.28) $0.09  $(1.54) $(0.46)Net (loss) income per share – diluted $(0.28) $0.09  $(1.54) $(0.46)                 Weighted average shares outstanding – basic  17,692   14,702   16,063   14,558 Weighted average shares outstanding – diluted  17,692   14,711   16,063   14,558  Beam Global
Reconciliation of Net Loss to Non-GAAP Net Loss
(Unaudited, In thousands)  Three Months Ended  Nine Months Ended   September 30,  September 30,   2025  2024  2025  2024                  GAAP Total Revenue $5,788  $11,482  $19,187  $40,855                  GAAP Total COGS  5,816   10,251   17,280   35,789 Adjusted to exclude the following:                Depreciation and Amortization  767   788   2,225   2,424 Non-GAAP Total COGS $5,049  $9,463  $15,055  $33,365                  Non-GAAP Gross Profit $739  $2,019  $4,132  $7,490 Non-GAAP Gross Margin %  13%  18%  22%  18%                 GAAP Total Operating Expenses $4,844  $(50) $26,790  $11,623                  Adjusted to exclude the following:                Depreciation and Amortization  115   141   421   421 Non-cash Compensation  759   667   2,785   1,843 Allowance for Credit Losses  370   –   1,261   378 Warrant Amortization  80   161   241   322 Change in fair value of contingent consideration liabilities  (50)  –   (50)  – Impairment of Goodwill  –   (6,077)  10,780   (4,545)Non-GAAP Total Adjustments $1,282  $(5,108) $15,438  $(1,581)                 Non-GAAP Total Operating Expenses $3,561  $5,058  $11,352  $13,204                  GAAP Other Expenses $2  $18  $212  $(97)                 GAAP Net Loss $(4,870) $1,299  $(24,671) $(6,654)Non-GAAP Total Adjustments  2,050   (4,321)  17,663   843 Non-GAAP Net Loss $(2,820) $(3,022) $(7,008) $(5,811)

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Q1: 2025-11-13 Earnings SummaryEPS of -$0.53 beats by $0.00

 |

Revenue of

$0.00

beats by $0.00

NioCorp Developments Ltd. (NB) Morgan Stanley Virtual National Security & Critical Materials Symposium November 14, 2025 10:15 AM EST

Company Participants

Mark Smith - Executive Chairman, President & CEO

Conference Call Participants

Carlos de Alba - Morgan Stanley, Research Division

Presentation

Carlos de Alba
Morgan Stanley, Research Division

This last session of the Mining Symposium on Critical Minerals and rare earths. It is a pleasure to host NioCorp. Mark Smith is Executive Chairman, President and CEO. And we also have Jim Sims in the forum. We're going to keep it hopefully very conversational. You can also meet questions via the Zoom app. We will read it once we get it for Mark or Jim to answer. But before we begin, please let me mention some disclaimers. Please note that this webcast is for Morgan Stanley clients and select employees or appropriate employees, I should say. This webcast is not for members of the press.

And if you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. All right. So with that out of the way, Mark, the -- we're going to just keep it conversational, as I said, we have some questions, [ Mark ] and I and then as the audience starts to send theirs, we'll also ask them to answer those, please. Maybe just to set the stage and before I pass it on to Mark, would you just present a brief introduction of the company, a little bit of the history, and then we kick it off from there.

Mark Smith
Executive Chairman, President & CEO

Very good, Carlos. And again, thank you -- and [ Mark ] for this wonderful opportunity. I think this

Recommended For You

NORTHVALE, NJ / ACCESS Newswire / November 14, 2025 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2025 of Fiscal Year 2026. The Company continued its positive momentum in revenues this fiscal year, building on the gains reported in the Annual 10-K Report for the fiscal year ended March 31, 2025, and the first fiscal quarter ended June 30, 2025.

November 14, 2025 16:39 ET

 | Source:

Maui Land & Pineapple Company, Inc.

KAPALUA, Hawaii , Nov. 14, 2025 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the quarter ended September 30, 2025.

"Our third-quarter results reflect the successful execution of our strategic initiatives, highlighted by a 39% increase in recurring leasing revenue year-over-year. This remarkable growth was complemented by strong progress in our land development segment, demonstrating our commitment to unlocking the value of our assets and accelerating the growth in housing, economic vitality and employment on Maui." said Race Randle, CEO, Maui Land & Pineapple Company, Inc.

Notable achievements this period include the following:

Recurring revenue from our leasing segment increased 39% year to date in 2025 as compared to the same period in 2024 and 59% when compared to the same period in 2023. The Company welcomed a variety of new commercial, industrial and land lease tenants in both Upcountry and West Maui, including the new Maui Pineapple Store and Malia Coffee Company in Hali‘imaile, Maui Sunriders Bike Shop and Big Wave Shave Ice in Kapalua, and the 1,000+ acre Ka Ike Cattle Ranch in West Maui. We continue to focus attention on opportunities to enhance this recurring revenue through improved occupancy and purposeful placemaking.Sale of three land parcels through the third quarter of 2025, following an in-depth review of landholdings to identify non-strategic landholdings to market for incremental liquidity as we advance planning and development of active projects. The Company currently has five additional parcels publicly marketed for sale and recently closed on a parcel sale in October 2025.Launch of new agriculture venture with hiring Director of Agricultural Operations, Darren Strand, and planting 15,000 blue weber agave plants on 25 acres of underutilized croplands in Upcountry, Maui. With decades of experience farming on Maui, Strand will advance efforts for the Company to develop value-added products with this drought tolerant crop.We fulfilled our largest remaining legacy obligation to the Company’s former employees by funding, annuitizing, and terminating the qualified pension at an expense of $6.9 million. The final remaining pension obligation is scheduled to be resolved in the fourth quarter of 2026. Third Quarter 2025 Financial Highlights from the Company’s 10Q

"We are pleased to have achieved positive Adjusted EBITDA year-to-date, a meaningful improvement over 2024 which reflects our operational progress and position for continued growth," added Randle.

Operating Profit/Loss improved by 48.4%: ($2.8) million compared to ($5.5) million, an improvement of $2.7 million for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024.
Operating Revenues increased by 83.1%: $14.9 million compared to $8.2 million, an improvement of $6.8 million for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. This is partially attributed to $3,376,000 of cost reimbursements from the Relief Housing Project with the State of Hawai‘i, which has been paused pending further direction from the State. Operating Costs and expenses increased 30.1%: $17.8 million compared to $13.7 million, an increase of $4.1 million for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The increase in operating costs was primarily attributed to $3,376,000 of direct costs from the Relief Housing Project with the State of Hawai‘i, which were reimbursed by the State. Adjusted EBITDA (Non-GAAP) increased by $1.7 million – Adjusted EBITDA for the nine months ended September 30, 2025, was $1.6 million. This represents an increase of $1.7 million as of September 30, 2025, as compared to ($0.1) million for the nine months ended September 30, 2024.Land development and sales business segment’s net operating income improved by 203.9%: $0.5 million compared to ($0.5) million for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The increase in margin is due to three parcel sales in Upcountry and West Maui in the current year as compared to one parcel sale during the same nine-month period in 2024.Leasing segment’s net operating income improved by 21.5%: $4.5 million compared to $3.7 million, an increase of $0.8 million for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. This increase was the result of focused efforts to improve occupancy, update leases to market rates, reposition renovated commercial properties and lease underutilized croplands. From late 2024 to September 30, 2025, approximately 30 leases were executed and commenced. The Company anticipates continued increases in recurring net operating income as occupancy stabilizes and origination costs related to new leases subsides.Combined General and administrative and Share-based compensation expenses decreased by 16.0%: $6.7 million compared to $8.0 million, a decrease of $1.3 million for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The decrease was primarily driven by a $1.6 million reduction in share-based compensation due to a reduced use of options. The Company does not anticipate using options for director compensation in the future, which the Company expects to result in a decrease in share-based compensation expenses in future periods.GAAP Net loss increased by $3.9 million primarily due to expense recognition for the pension termination: GAAP net loss was ($9.4) million, or ($0.48) per basic and diluted common share for the nine months ended September 30, 2025, compared to net loss of ($5.5) million or ($0.28) per basic and ($0.27) per diluted common share for the same period in 2024. The net loss September 30, 2025, was primarily driven by $6.9 million in pension expenses, of which $6.6 million was non-cash and resulted from the qualified pension plan termination which was finalized on September 30, 2025. The Company has fulfilled its obligation to its former employees to ensure their pensions have been fully funded and annuitized. There remains an unfunded Supplemental Employees Retirement Plan ("SERP") that is comprised of eight participants. The SERP is scheduled to be terminated in the fourth quarter of 2026 at an estimated cost of $1.6 million.
Cash and Investments Convertible to Cash (Non-GAAP) – Cash and Investments Convertible to Cash totaled $5.0 million on September 30, 2025, a decrease of $4.5 million, as compared to $9.5 million at December 31, 2024. The decrease in cash is primarily attributed to $1.0 million in cash pension termination contributions and approximately $3.4 million of cash expended on furthering our land development activities, stabilizing our leased assets, capital expenditures across the portfolio, and launch of our new agave venture. Non-GAAP Financial Measures

Certain non-GAAP financial measures are presented in this press release, including Adjusted EBITDA and Cash and Investments Convertible to Cash, to provide information that may assist investors in understanding the Company's financial results and financial condition and assessing its prospects for future performance. We believe that Adjusted EBITDA is an important indicator of our operating performance because it excludes items that are unrelated to, and may not be indicative of, our core operating results. We believe Cash and Investments Convertible to Cash are important indicators of liquidity because it includes items that are convertible into cash in the short term. These non-GAAP financial measures are not intended to represent and should not be considered more meaningful measures than, or alternatives to, measures of operating performance or liquidity as determined in accordance with GAAP. To the extent we utilize such non-GAAP financial measures in the future, we expect to calculate them using a consistent method from period to period.

EBITDA is a non-GAAP financial measure defined as net income (loss) excluding interest, taxes, depreciation and amortization. Adjusted EBITDA is further adjusted for non-cash stock-based compensation expense, pension and post-retirement expenses, and bad debt. Adjusted EBITDA is a key measure used by the Company to evaluate operating performance, generate future operating plans and make strategic decisions for the allocation of capital. The Company presents Adjusted EBITDA to provide information that may assist investors in understanding its financial results. However, Adjusted EBITDA is not intended to be a substitute for net income (loss). A reconciliation of Adjusted EBITDA to the most directly comparable GAAP financial measure is provided further below.

Cash and Investments Convertible to Cash is a non-GAAP financial measure defined as cash and cash equivalents plus investments convertible to cash within forty-eight hours. Cash and Cash Investments Convertible to Cash is a key measure used by the Company to evaluate internal liquidity.

Additional Information

More information about Maui Land & Pineapple Company’s second quarter 2025 operating results are available in the Form 10-Q filed with the Securities and Exchange Commission and posted at mauiland.com.

About Maui Land & Pineapple Company 

Maui Land & Pineapple Company, Inc. (NYSE: MLP) is dedicated to the thoughtful stewardship of its portfolio, including over 22,000 acres of land along with approximately 247,000 square feet of commercial real estate. The Company envisions a future where Maui residents thrive in more resilient communities with sufficient housing supply, economic stability, food and water security, and deep connections between people and place. For over a century, MLP has built a legacy of thoughtful stewardship through conservation, agriculture, community building, and land management. The Company continues this legacy today with a mission to thoughtfully maximize the productive use of its assets to meet the critical needs of current and future generations.

Company assets include land for future residential communities and mixed-use projects within the world-renowned Kapalua Resort, home to luxury hotels such as The Ritz-Carlton Maui and Montage Kapalua Bay, pristine beaches, a network of walking and hiking trails, and the Pu‘u Kukui Watershed, the largest private nature preserve in Hawai‘i. 

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding the Company’s ability to put its land into productive use, our ability to cultivate and commercialize Agave, our ability to market and sell nonstrategic parcels in our portfolio, and our ability to reduce share-based compensation expenses. These forward-looking statements are based upon the current beliefs and expectations of management and are inherently subject to significant business, economic and competitive uncertainties, and contingencies, many of which are beyond the control of the Company. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Actual results may differ materially from the anticipated results discussed in these forward-looking statements because of possible uncertainties. Factors that could cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the Company's reports (such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K) filed with the SEC and available on the SEC's Internet site (http://www.sec.gov). We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether because of new information, future developments or otherwise.

# # #

CONTACT
Investors:Wade Kodama | Chief Financial Officer | Maui Land & Pineapple Company e: [email protected]   Media:Ashley Takitani Leahey | Vice President | Maui Land & Pineapple Company e: [email protected]  Dylan Beesley | Senior Vice President | Bennet Group Strategic Communications e: [email protected]  MAUI LAND & PINEAPPLE COMPANY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(Unaudited)
      Nine Months Ended
September 30,   2025  2024   (in thousands except   per share amounts) OPERATING REVENUES                 Land development and sales $4,211  $200 Leasing  9,947   7,148 Resort amenities and other  774   805 Total operating revenues  14,932   8,153          OPERATING COSTS AND EXPENSES        Land development and sales  3,705   687 Leasing  5,450   3,447 Resort amenities and other  1,066   992 General and administrative  3,654   3,336 Share-based compensation  3,075   4,676 Depreciation  831   531 Total operating costs and expenses  17,781   13,669          OPERATING LOSS  (2,849)  (5,516)         Gain on asset disposal  1   - Other income  525   271 Pension and other post-retirement expenses  (6,914)  (234)Interest expense  (162)  (5)NET LOSS $(9,399) $(5,484)Other comprehensive income - pension, net  6,676   204          TOTAL COMPREHENSIVE LOSS $(2,723) $(5,280)         NET LOSS PER COMMON SHARE-BASIC $(0.48) $(0.28)NET LOSS PER COMMON SHARE-DILUTED $(0.48) $(0.27) MAUI LAND & PINEAPPLE COMPANY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS         September 30,
2025  December 31,
2024   (unaudited)  (audited)   (in thousands except share data) ASSETS        CURRENT ASSETS        Cash and cash equivalents $4,926  $6,835 Accounts receivable, net  2,412   5,016 Investments  120   2,687 Prepaid expenses and other assets  1,065   507 Assets held for sale  1,598   82 Total current assets  10,121   15,127          PROPERTY & EQUIPMENT, NET  17,530   17,401          OTHER ASSETS        Investment in unconsolidated joint venture  -   968 Deferred development costs - development projects  14,528   14,380 Deferred development costs - Agave venture  1,032   30 Other noncurrent assets  2,628   2,233 Total other assets  18,188   17,611 TOTAL ASSETS $45,839  $50,139          LIABILITIES & STOCKHOLDERS' EQUITY        LIABILITIES        CURRENT LIABILITIES        Accounts payable $2,070  $2,321 Payroll and employee benefits  584   908 Accrued retirement benefits, current portion  140   140 Deferred revenue, current portion  904   833 Long-term debt, current portion  85   85 Line of credit  3,000   3,000 Other current liabilities  564   730 Contract overbillings  -   3,180 Total current liabilities  7,347   11,197          LONG-TERM LIABILITIES        Accrued retirement benefits, noncurrent portion  1,451   2,368 Deferred revenue, noncurrent portion  1,133   1,233 Deposits  1,938   1,968 Long-term debt, noncurrent portion  123   168 Other noncurrent liabilities  125   24 Total long-term liabilities  4,770   5,761 TOTAL LIABILITIES  12,117   16,958          COMMITMENTS AND CONTINGENCIES                 STOCKHOLDERS' EQUITY        Preferred stock--$0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding  -   - Common stock--$0.0001 par value; 43,000,000 shares authorized; 19,742,880 and 19,663,780 shares issued and outstanding at September 30, 2025, and December 31, 2024, respectively  87,318   85,877 Additional paid-in-capital  17,025   15,202 Accumulated deficit  (70,407)  (61,008)Accumulated other comprehensive loss  (214)  (6,890)Total stockholders' equity  33,722   33,181 TOTAL LIABILITIES & STOCKHOLDERS' EQUITY $45,839  $50,139  MAUI LAND & PINEAPPLE COMPANY, INC. AND SUBSIDIARIES
SUPPLEMENTAL FINANCIAL INFORMATION
(NON-GAAP) UNAUDITED
      Nine Months Ended   September 30,   2025  2024   (In thousands except per share   amounts)          NET LOSS $(9,399) $(5,484)Non-cash income and expenses        Interest expense  5   5 Depreciation  831   531 Amortization of licensing fee revenue  (100)  (100)Share-based compensation        Vesting of Stock Options granted to Board Chair and Directors  1,221   2,890 Vesting of Stock Compensation granted to Board Chair and Directors  556   426 Vesting of Stock Options granted to CEO  603   599 Vesting of employee Incentive Stock  695   761 Bad debt expense and impairments  299   64 Pension and other post-retirement expenses  6,914   234          ADJUSTED EBITDA (LOSS) $1,625  $(74)   Nine Months
Ended  Year Ended   September 30,
2025  December 31,
2024   (unaudited)  (audited)   (in thousands)          CASH AND INVESTMENTS        Cash and cash equivalents $4,926  $6,835 Investments, current portion  120   2,687 TOTAL CASH AND INVESTMENTS CONVERTIBLE TO CASH $5,046  $9,522 

The third-quarter earnings season is wrapping up and most reports from commercial space companies are in. Here's a look at the details from the space sector's Q3 reports. 

RKLB stock is moving. See the real-time price action here. 
Rocket Lab – RKLB Rocket Lab Corp. (NASDAQ:RKLB) reported its third-quarter results after Monday's closing bell with revenue of $155.05 million which beat the consensus estimate of $151.75 million. 

The end-to-end space company reported a third-quarter loss of three cents per share, beating analyst estimates for a loss of 11 cents per share, according to Benzinga Pro.

"This past quarter we've once again delivered record revenue of $155m at record GAAP gross margin of 37%, and a new annual launch record is just days away," said Peter Beck, founder and CEO of Rocket Lab.

Read Next: Shkreli’s Shorts Up 600% As Quantum Stocks Tank

AST SpaceMobile – ASTSOn Monday, AST SpaceMobile, Inc. (NASDAQ:ASTS) reported quarterly losses of 45 cents per share, which missed the analyst estimate for losses of 23 cents.

Quarterly revenue came in at $14.73 million, which missed the consensus estimate of $19.93 million.

However, the company reaffirmed its second-half 2025 revenue guidance of between $50 million and $75 million.

Virgin Galactic – SPCE Virgin Galactic Holdings, Inc. (NYSE:SPCE) reported its Q3 results after Thursday's closing bell with revenue of $365,000, flat from the prior year’s third quarter, and a loss of $1.09 per share. 

Virgin Galactic said the Flight Test Program is on track to commence in the third quarter of 2026, with the first commercial spaceflights on track for the fourth quarter of 2026.

Private astronaut flights are expected to begin six to eight weeks after the first commercial flight of 2026.

SPCE stock climbed on the spaceflight update and narrower-than-anticipated loss per share. 

Read Next: Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks

Firefly Aerospace – FLY Firefly Aerospace, Inc. (NASDAQ:FLY) reported revenue of $30.78 million for the third quarter on Wednesday, beating estimates of $27.71 million. 

The company reported a third-quarter adjusted loss of 33 cents per share, beating estimates for a loss of 41 cents per share, per Benzinga Pro.

"Our strong third quarter revenue growth reflects steady execution of our spacecraft teams on multiple contracts as well as progress made by our launch teams," said CEO Jason Kim.

Firefly raised its full-year 2025 revenue guidance to a new range of $150 million to $158 million. Analysts had been anticipating full-year revenue of $135.49 million.

Sidus Space – SIDU Sidus Space, Inc. (NASDAQ:SIDU) is set to release its Q3 earnings report after Friday's closing bell and will host a conference call at 5 p.m. ET to discuss the results. 

The company reported losses of 31 cents per share and revenue of $1.26 million last quarter, according to data from Benzinga Pro. 

Intuitive Machines, Inc. (NASDAQ:LUNR) has not yet confirmed a date for its third-quarter earnings release. Benzinga Pro shows an estimated date of Nov. 25, though investors await confirmation from the company. 

Read Next: 

 Quantum Stock Tracker: IonQ, Rigetti, D-Wave Report Q3 Earnings
Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

H&R Real Estate Investment Trust (HR.UN:CA) Q3 2025 Earnings Call November 14, 2025 9:30 AM EST

Company Participants

Thomas Hofstedter - CEO & Executive Chairman
Larry Froom - Chief Financial Officer
Emily Watson - Chief Operating Officer of Lantower Residential

Conference Call Participants

Sam Damiani - TD Cowen, Research Division
Frederic Blondeau - Green Street Advisors, LLC, Research Division
Mario Saric - Scotiabank Global Banking and Markets, Research Division
Khing Shan - RBC Capital Markets, Research Division
Matt Kornack - National Bank Financial, Inc., Research Division
Tal Woolley - CIBC Capital Markets, Research Division

Presentation

Operator

Good morning, and welcome to H&R Real Estate Investment Trust 2025 Third Quarter Earnings Conference Call. Before beginning the call, H&R would like to remind listeners that certain statements, which may include predictions, conclusions, forecasts or projections and the remarks that follow may contain forward-looking information, which reflect the current expectations of management regarding future events and performance and speak only as of today's date.

Forward-looking information requires management to make assumptions or rely on certain material factors and is subject to inherent risks and uncertainties, and actual results could differ materially from the statements in the forward-looking information. In discussing H&R's financial and operating performance and in responding to your questions, we may reference certain financial measures, which do not have a meaning recognized or standardized under IFRS or Canadian generally accepted accounting principles and are therefore unlikely to be comparable to similar measures presented by other reporting issuers.

Non-GAAP measures should not be considered as alternatives to net income or comparable metrics determined in accordance with IFRS as indicators of H&R's performance, liquidity, cash flows and profitability. H&R's management uses these measures to aid in assessing the REIT's underlying performance and provides these additional measures so that investors can do the same.

Additional information about the material

Recommended For You

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $10.1 million for the third quarter of 2025 and an operating loss of $3.7 million for the period, as compared to total net sales for the same period last year of $10.3 million and an operating loss of $5.1 million. For the first nine months of the year, net sales were $28.8 million and operating losses were $13.5 million as compared to 2024 net revenues of $24.0 million and operati.

Doug McMillon surprised investors with his retirement announcement. Here's what it means.

Walmart (WMT 0.22%) CEO Doug McMillon, who just announced his retirement, doesn't get as much credit as tech titans like Jeff Bezos and Elon Musk do, but he's been one of the best CEOs of the 21st century.

McMillon took over the retail giant in 2014 at a time when it was flailing as Amazon was ascendant. Walmart stock had essentially gone nowhere for over a decade, and the company failed to adequately update its business model for the e-commerce era, essentially ignoring the threat from Amazon.

As you can see from the chart below, despite a weak start under McMillon as he made needed changes, Walmart has beaten the S&P 500 during his tenure, something many of its brick-and-mortar retail peers have not done.

Over the last five years, Walmart has even outperformed Amazon by a wide margin.

How McMillon revamped Walmart
Among McMillon's first steps was ramping up capital expenditures (capex) and shifting Walmart's focus to the omnichannel and e-commerce rather than building new stores. He wisely recognized that Walmart had saturated the country with stores and could leverage them in the online channel through grocery pick-up stations. That was a key investment strategy under his watch, as the company added kiosks to its stores so customers could order groceries online and seamlessly pick them up. The strategy resonated with customers, got them accustomed to ordering on Walmart.com, and notably offered something Amazon couldn't provide.

McMillon made e-commerce his north star. The company acquired Jet.com and folded it into Walmart, putting e-commerce wiz Marc Lore in charge of its online operations, and borrowed ideas from Amazon where it made sense. That included launching a Prime-like membership program, Walmart+, expanding its e-commerce marketplace, and launching a media network to monetize its website app through advertising.

Under his watch, Walmart also rearranged its international portfolio, pulling out of markets where it struggled, like Brazil, and investing in growth opportunities.

Image source: Walmart.

What's next for Walmart
John Furner, the current Walmart U.S. CEO, will take over for McMillon in February. Walmart stock pulled back modestly on the announcement, but the transition should be smooth. Furner has been in that position for six years, and Walmart seems to be well positioned for growth, having overcome the earlier challenge it faced in e-commerce.

McMillon will also remain on the board of directors for an additional year after his retirement to help with the transition.

Walmart stock isn't cheap at this point, trading at a price-to-earnings ratio of 39, but that's a reflection of the premium that McMillon has helped it earn. While the company has built a formidable e-commerce operation, it also retains strengths in economies of scale and low prices. That's been an advantage in an inflationary environment, and it should continue to be one going forward.

Even as McMillon will be missed, the future looks bright for Walmart.

November 14, 2025 3:18 PM EST | Source: Levi & Korsinsky, LLP
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your CarMax, Inc. (NYSE: KMX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

https://zlk.com/pslra-1/carmax-inc-lawsuit-submission-form?prid=177491&wire=5&utm_campaign=26

or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

THE LAWSUIT: A class action securities lawsuit was filed against CarMax, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between June 20, 2025 and September 24, 2025.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants recklessly overstated CarMax's growth prospects when, in reality, its earlier growth in the 2026 fiscal year was a temporary benefit from customers buying cars due to speculation regarding tariffs; and (2) as a result, defendants' statements about CarMax's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

WHAT'S NEXT? If you suffered a loss in CarMax, Inc. stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/carmax-inc-lawsuit-submission-form?prid=177491&wire=5&utm_campaign=26 to learn about your rights to seek a recovery. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274618

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / For decades, industries have treated physical goods and digital systems as separate worlds. Software evolved.

Metallium Limited (OTC:MTMCF) Morgan Stanley Virtual National Security & Critical Materials Symposium November 14, 2025 9:30 AM EST

Company Participants

Michael Walshe - CEO, MD & Director

Presentation

Unknown Analyst

Yes. Good morning, everyone. Thank you very much for joining us in this session. Good afternoon, good evening, good night to Michael, who is joining us from Australia quite late there. I really appreciate Michael, very good to have you.

Michael Walshe
CEO, MD & Director

Thanks very much for the opportunity.

Unknown Analyst

Yes. So look, Michael is the CEO of Metallium and sort of company that is presenting a very novel solution to some of the problems that the world is facing right now on the critical mineral space. So it's a great addition to the agenda and looking forward to the conversation. We want to keep it quite casual. We have a lot of participants. And ideally, you can or you will submit your questions. That will really enhance the level of the discussion.

Before we begin, let me just read some disclaimers. Please note that this webcast is for Morgan Stanley clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. And if you are a member of the press, please disconnect and reach out separately. For important disclosures, please go to Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

Question-and-Answer Session

Unknown Analyst

All right. With that out of the way, Maybe, Michael, why don't you introduce yourself to get us going and maybe introduce a little bit of the history of the company, how it came about before we move -- I pass it on to Mark to get us going with other questions.

Recommended For You

November 14, 2025 3:25 PM EST | Source: Levi & Korsinsky, LLP
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your James Hardie Industries plc. (NYSE: JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=177493&wire=5&utm_campaign=6

or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

Cannot view this video? Visit:
https://www.youtube.com/watch?v=WIT6IS25cnc

THE LAWSUIT: A class action securities lawsuit was filed against James Hardie Industries plc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 20, 2025 and August 18, 2025.

CASE DETAILS: According to the filed complaint, defendants made false statements and/or concealed the following adverse facts pertaining to James Hardie's North America segment: (a) primary consumer demand and growth in James Hardie's North America segment were deteriorating; (b) overstocking was the primary driver of North America growth during the Class Period, not primary consumer demand; (c) a result, there was excessive inventory at James Hardie's North America distributors.

WHAT'S NEXT? If you suffered a loss in James Hardie Industries plc. stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=177493&wire=5&utm_campaign=6 to learn about your rights to seek a recovery. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274620

Kitco News

The Leading News Source in Precious Metals

Kitco NEWS has a diverse team of journalists reporting on the economy, stock markets, commodities, cryptocurrencies, mining and metals with accuracy and objectivity. Our goal is to help people make informed market decisions through in-depth reporting, daily market roundups, interviews with prominent industry figures, comprehensive coverage (often exclusive) of important industry events and analyses of market-affecting developments.

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline.

SO WHAT: If you purchased or sold Cepton common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Cepton class action, go to https://rosenlegal.com/submit-form/?case_id=45981 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. If you wish to serve as lead plaintiff, you must move the Court no later than December 8, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements regarding Cepton’s business, operations, and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) Cepton had received a credible third-party bid valuing Cepton at more than double the Koito Acquisition (Cepton’s merger with Koita Manufacturing Co., Ltd.); (2) Cepton’s Board of Directors failed to meaningfully explore the foregoing offer and failed to disclose its terms when recommending that Cepton’s shareholders approve the Koito Acquisition; (3) consequently, Cepton’s shareholders were deprived of the opportunity to meaningfully consider whether to accept or reject the Koito Acquisition; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times.

To join the Cepton class action, go to https://rosenlegal.com/submit-form/?case_id=45981 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

November 14, 2025 3:35 PM EST | Source: Levi & Korsinsky, LLP
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ: MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=177495&wire=5&utm_campaign=23

or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

Cannot view this video? Visit:
https://www.youtube.com/watch?v=N2O8MkyANRE

THE LAWSUIT: A class action securities lawsuit was filed against MoonLake Immunotherapeutics that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between March 10, 2024 and September 29, 2025.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) It's sole drug candidate, SLK and BIMZELX share the same molecular targets (the inflammatory cytokines IL-17A and IL-17F); (2) SLK's distinct Nanobody structure would not confer a superior clinical benefit over the traditional monoclonal structure of BIMZELX; (3) SLK's distinct Nanobody structure supposed increased tissue penetration would not translate to clinical efficacy; and (4) based on the foregoing, defendants lacked a reasonable basis for their positive statements regarding SLK's purported superiority to monoclonal antibodies.

WHAT'S NEXT? If you suffered a loss in MoonLake stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=177495&wire=5&utm_campaign=23 to learn about your rights to seek a recovery. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274622

November 14, 2025 3:38 PM EST | Source: Levi & Korsinsky, LLP
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your Synopsys, Inc. (NASDAQ: SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=177496&wire=5&utm_campaign=7

or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

THE LAWSUIT: A class action securities lawsuit was filed against Synopsys, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between December 4, 2024 and September 9, 2025.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the extent to which the Company's increased focus on artificial intelligence customers, which require additional customization, was deteriorating the economics of its Design IP business; (2) that, as a result, "certain road map and resource decisions" were unlikely to "yield their intended results;" (3) that the foregoing had a material negative impact on financial results; and (4) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT'S NEXT? If you suffered a loss in Synopsys, Inc. stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=177496&wire=5&utm_campaign=7 to learn about your rights to seek a recovery. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274623

Time flies when you’re making money.

Hard to believe there’s only 6½ weeks left before 2025 comes to a close.

It’s been a great year so far. YTD, the Dow is up 11.6%; the S&P is up 14.6%; and the Nasdaq is up 18.4%.

And it looks like there’s a lot more upside to go.

For one, Q4 is historically the best quarter for stocks. So, there’s that.

Additionally, since 1950, in post-election years (i.e., the first year after a Presidential election), both November and December have a high probability of finishing in the plus column, with a 72.2% likelihood for November and a 77.8% likelihood for December.

And there’s a myriad of other reasons why, beyond just the recurring seasonal tendency.

That includes the tamer inflation reports, the resiliency of the economy, the recent interest rate cuts (and one more cut expected in mid-December), and of course, the ongoing AI boom!

For those who missed the recent rally, or wished they would have taken better advantage of it, the good news is the next leg up could be even more spectacular.

And that’s exactly what I’m expecting.

History Repeats Itself

Last year saw the S&P 500 soar by 23.3%.

That was the second year in a row of 20%+ gains. (2023 was up 24.2%.)

That’s a feat rarely seen in the past.

In fact, it was the first time it was up 20% or more for two years in a row since 1995-1996.

In 1995 the S&P was up 34.1%. That was the beginning of the dot-com (technology) boom.

In 1996 it was up 20.3%.

So, what happened in 1997? It was up another 31.0%.

1998? Up another 26.7%.

And in 1999, it was up 19.5%.

A spectacular rally that lasted 5 long, glorious years.

Yes, the dot-com bubble arrived in 2000. But not before people got rich over the preceding 5 years with a 220% increase in the S&P, while plenty of individual stocks were up several hundred percent to several thousand percent.

And I believe we could possibly see the same thing again now. Maybe 5 years or more of boom times – for similar reasons, and some unique to the present day.

Tech Booms: Past And Present (Dot-Com to AI)

The tech boom back then saw everybody go nuts for technology stocks, driven by the internet and dot-com companies.

It was new and exciting. And the internet was forecast to change the way people shopped, did business, and interacted with each other.

The promise was real, as we now know.

So, what’s the parallel?

In part, it’s another tech boom.

But this modern technology boom is being driven by Artificial Intelligence (AI).

And it’s forecast to be just as transformative as the personal computer, the internet and the mobile phone. And it’s expected to touch virtually every industry in some way shape or form, as well as impact ordinary lives.

The AI trade has worked so well for a reason -- because the AI boom is real, and is supported by real earnings, and real growth potential.

But there are plenty of other catalysts that make the market outlook even more exciting.

Continued . . .

------------------------------------------------------------------------------------------------------

Saturday Deadline: Claim your Free Copy of Finding #1 Stocks

One single idea changed Kevin Matras’ life as an investor, allowing him to tap into the greatest force driving stock prices. In Finding #1 Stocks, Kevin explains his top stock-picking secrets and strategies based on this powerful concept.

In 2024…while the market gained +27.4%...these strategies produced gains up to +307.1%.¹

You can take full advantage of them without attending a single class or seminar, in a lot less time than you think. Opportunity ends midnight Saturday, November 15.

Get your free book now >>

------------------------------------------------------------------------------------------------------

The AI Trade Is Alive And Well

Yes, I know, there are some who think AI is in a bubble.

Don’t believe it.

The AI trade is alive and well. And will likely be one of the key drivers for stocks for years to come.

The latest comment underscoring the AI trade comes from AMD CEO Lisa Su, who just last week characterized the demand for AI as “insatiable,” and said her company alone could grow by 35% a year for the next 3-5 years because of that. In fact, she said the AI market is "faster than anything we've seen before.” And she predicted the AI data center market could grow to “$1 trillion” by 2030.

A resounding outlook for the scale of AI.

Here’s a few more, by NVIDIA CEO Jensen Huang:

“AI is the most powerful technology force of our time.”

“AI will revolutionize every industry, from healthcare to transportation.”

“We are at the beginning of a new computing era.”

Yes, AI stocks have moved a lot. Some are at high valuations. But we are still relatively early in the AI revolution.

The amount of investment in AI will dwarf that of the dot-com era. In fact, it already has. And the unprecedented spending and innovation is expected to last for years to come.

While it transforms the world as we know it, it also has the potential to transform one’s portfolio.

Inflation And Interest Rates

While inflation is still too high, it’s been more moderate than the Fed had been worrying about.

Before the shutdown, the last Consumer Price Index (CPI, retail inflation) report showed core inflation (ex-food & energy) at 3.1% y/y, down from 3.3% a few months back.

The Producer Price Index (PPI, wholesale inflation), eased to 2.8% y/y, down from the previous month’s 3.7%.

And the Personal Consumption Expenditures (PCE) index (the Fed’s preferred inflation gauge), came in at 2.9%, the same as the previous month, and forecasts for the same.

This, in part, gave the Fed the green light to cut interest rates by 25 basis points in September (the first cut in a year), and cut another 25 basis points in October. And with the Fed’s forecast of 3 rate cuts by year’s end, that leaves one more cut at their next FOMC meeting on December 9-10.

And given the market is a forward-looking mechanism, it does not seem to be wasting any time in acting on that.

Plus, as interest rates continue to fall, you can be sure plenty of money tied up in money markets will find their way back into equities, further supporting stock prices.

The Earnings Outlook Is For Growth

Let’s also not forget that earnings are the main driver of stock prices.

Ironically, while everyone was fretting over tariffs, the earnings picture never wavered and continues to point to growth.

Q3’25 earnings season just put in another better-than-expected showing.

Q4 earnings growth is forecast at 7.3%.

Q1’26 is forecast at 9.7%.

And Q2’26 is forecast at 11.0%.

While tariff fears and even recession fears shook the market previously, none of that is showing up in the aggregate earnings estimates.

And again, earnings are the key driver of stock prices.

Small-Caps Are Also On The Rise

The bull market rally, which is in its third year, is broadening.

Tech is still a big driver. And will be for years to come. But other industries are breaking out as well. And categories.

That includes small-caps.

Adding fuel to the small-cap rally will definitely be the aforementioned and expected interest rate cuts.

All-sized borrowers should see relief with lower interest rates. But since small-caps tend to have a larger proportion of debt than their larger counterparts, and often borrow at less favorable terms, the continuing interest rate cuts should have a sizable impact on small-caps.

Additionally, the budget bill that passed in the summer, which included additional tax provisions for corporate America, not the least of which is the 100% immediate expensing of capital expenditures, will also have a positive impact.

Especially since small-caps are typically in the earlier part of their growth cycle. Those tax provisions should allow them to spend/invest more money, accelerate their growth plans, and get the entire tax benefit in year one.

In addition to the AI boom, I think we’re on the cusp of a small-cap renaissance as well.

Do What Works

So, how do you fully take advantage of the market right now?

By implementing tried and true methods that work to find the best stocks.

For example, did you know that stocks with a Zacks Rank #1 Strong Buy have beaten the market in 29 of the last 37 years (a 78% win ratio) with an average annual return of more than 24% per year? That's more than 2 x the S&P, including 4 bear markets and 4 recessions. And consistently beating the market year after year can add up to a lot more than just two times the returns.

It also killed in 1995 with a 52.6% gain; 1996 with 40.9%; 1997 with 43.9%; 1998 with 19.5%; and 1999 with 45.9%. It was also up in 2000 by 14.3% while the S&P was down.

Did you also know that stocks in the top 50% of Zacks Ranked Industries outperform those in the bottom 50% by a factor of 2 to 1? There's a reason why they say that half of a stock's price movement can be attributed to the group that it's in. Because it's true!

Those two things will give any investor a huge probability of success and put you well on your way to beating the market.

But you’re not there yet, as those two items alone will only narrow down a field of 10,000 stocks to the top 100 or so. Way too many to trade at once.

So, the next step is to get that list down to the best 5-10 stocks that you can buy.

Proven Profitable Strategies

Picking the best stocks is a lot easier when there’s a proven, profitable method to do it.

And by concentrating on what has proven to work in the past, you’ll have a better idea as to what your probability of success will be now and in the future.

Of course, this won't preclude you from ever having another losing trade. But if your stock picking strategy picks winners more often than losers, you can feel confident that your next trade will have a high probability of success.

Here are a few of my favorite strategies that have regularly crushed the market year after year.

New Highs: Studies have shown that stocks making new highs have a tendency of making even higher highs. And this strategy proves it. The alignment of positive price action and strong fundamentals creates all the necessary conditions to see these stocks soar to even greater heights. Over the last 25 years (2000 through 2024), using a 1-week rebalance, the average annual return has been 37.6% vs. the S&P’s 7.7%, which is 4.9 x the market.

Small-Cap Growth: Small-caps have historically outperformed the market time and time again. Often these are newer companies in the early part of their growth cycle, which is when they grow the fastest. This strategy combines the aggressive growth of small-caps with our special blend of growth and valuation metrics for explosive returns. Over the last 25 years (2000 through 2024), using a 1-week rebalance, the average annual return has been 44.3%, beating the market by 5.8 x the returns.

Filtered Zacks Rank 5: This strategy leverages the Zacks Rank #1 Strong Buys, and adds two time-tested filters to narrow the list of stocks down to five high probability picks each week. Over the last 25 years (2000 through 2024), using a 1-week rebalance, the average annual return has been 48.4%, which is 6.3 x the market.

The best part about these strategies (aside from the returns) is that all of the testing and hard work has already been done. There’s no guesswork involved. Just point and click and start getting into better stocks on your very next trade.

Where To Start

There’s a simple way to add a big performance advantage for your stock-picking success. It's called the Zacks Method for Trading: Home Study Course.

With this fun, interactive online program, you can master the Zacks Rank in your own home and at your own pace. You don’t have to attend a single class or seminar.Zacks Method for Trading

covers the investment ideas I just shared and guides you to better trading step by step, plus so much more.

You'll quickly see how to get the most out of the proven system that has more than doubled the market for over three decades. Discover what kind of trader you are, how to find stocks with the highest probability of success, and how to trade them so you can consistently beat the market no matter where stock prices are headed.

You’ll get the formulas behind our top-performing strategies suited for a variety of different trading styles.

The best of these strategies produced gains up to +307.1% in 2024 while the S&P 500 gained +27.4%.¹

The course will also help you create and test your own stock-picking strategies.

Today is the perfect time to get in. I'm giving participants free hardbound copies of my book, Finding #1 Stocks, a $49.95 value. Its 300 pages unfold virtually every trading secret I’ve learned over the last 25 years to beat the market.

Please note: Copies of the book are limited and your opportunity to get one free ends midnight Saturday, November 15, unless we run out of books first. If you're interested, I encourage you to check this out now.

Find out more about Zacks Method for Trading: Home Study Course >>

Thanks and good trading,

Kevin

Zacks Executive VP Kevin Matras is responsible for all of our trading and investing services. He developed many of our most powerful market-beating strategies and directs the Zacks Method for Trading: Home Study Course.

¹ The individual strategies mentioned herein represent only a portion of the ones covered in the course.

A long-inactive Bitcoin address has suddenly come alive after more than a decade, moving a significant volume of BTC and sparking fresh debate about long-term holder behavior, market positioning, and short-term liquidity risks. On Thursday, on-chain data revealed that a Satoshi-era wallet transferred 12,000 BTC, worth around $1.4 billion at current prices.

Fri, 14/11/2025 - 18:53

Bitcoin miners are under severe pressure despite using efficient hardware

Cover image via www.freepik.com

Following Bitcoin's plunge below the $100,000 level, miners are finding it much more difficult to make money. 

With electricity costing $0.06 per kWh, even those miners who use efficient mining machines (27.5 watts per terahash) are barely breaking even at around $97,000 per Bitcoin.

Machines that are less efficient or have higher electricity costs are already be losing money. 

HOT Stories

Which miners are still profitable? The data provided by F2Pool shows a dramatic difference in profitability based on a miner's efficiency.

The most efficient hardware, such as the Antminer S21 XP Hyd. (12.0 W/T), has an electricity cost rate of only 43% of the current BTC price. This means it only needs Bitcoin to be at $41,585 to break even on electricity. This elite tier of hardware remains highly profitable at the current price level.

The other high-efficiency S21 models are close behind: all of them would manage to remain profitable with the Bitcoin price under $60,000.   

In stark contrast, many older and less efficient machines are currently unprofitable. 

For example, the Whatsminer M53 needs the price to be $100,694, and the Antminer S19 requires $118,641. The least efficient hardware on the list, the CopyMiner C7, needs an unsustainable price of $130,909 just to cover its electricity.

Bitcoin is currently changing hands at $95,290 following an enormous price plunge. 

Related articles